Viewing StudyNCT00275132



Ignite Creation Date: 2024-05-05 @ 4:35 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00275132
Status: COMPLETED
Last Update Posted: 2014-12-03
First Post: 2006-01-10

Brief Title: Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor: University College London
Organization: University College London

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-04
Start Date Type: None
Primary Completion Date: 2009-04
Primary Completion Date Type: ACTUAL
Completion Date: 2009-04
Completion Date Type: ACTUAL
First Submit Date: 2006-01-10
First Submit QC Date: January 10 2006
Study First Post Date: 2006-01-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-12-01
Last Update Post Date: 2014-12-03
Last Update Post Date Type: ESTIMATED